RE: Great Buying Opportunity13 Feb 2021 19:09
Covid 19 LFT is going to be a big market. See my posts I called out GDR at 40p. All de-rampers attacked me including Idiot like (4uk). ODX is about to rocket now. load up. please DYOR. The government contract is a game-changer.
This could be the turning point for ODX and investors who buy it now may end up with superb gains over time.
There are indeed positive developments underway for ODX. The most obvious of them of course is the production of Covid-19 testing kits.
But even otherwise, it noted in its previous financial update that sales are expected to improve from next year
It also reported headway in its food intolerance business. Notably, it has received regulatory approval from China and expects significant growth opportunities in the country. It’s optimistic about the potential demand for its product in the US market as well.
On the positive side, ODX is well diversified. As I’ve mentioned, the company also specialises in HIV and food intolerance testing equipment. What’s more, it doesn’t focus on one country or one market. When demand for Covid-19 tests does fall, ODX can devote more resources to its other two departments. The good thing is that the Covid-19 tests will provide the company with a great deal more cash than it used to have. So, it will be in a better financial shape to operate after the end of the pandemic.
"The Food Intolerance business valuation at c.£60m
"Chinese NMPA approval for the Food Detective self-test in November 2020 is expected to drive long-term revenues..... this could be valued at £40-80m, with a value today of £30-60m"
"VISITECT CD4 is potentially capable of generating substantial revenues.....We believe that this could be valued at £55-85m, a value today of £45-70m."
£60m + £80m + £70m = £210M = £1.17+
So without any mention of Covid, they value the company somewhere between (£60m+£30m+£45m) or £135m (75p per share) and (£60m +£80m+£85m) or £225m (£1.25 per share this is without Covid tests)
2M x £2 x 52 = £208M +(SSP £1.15)+£1.25 = £2.4
2M x £3 x 52 = £312M
2M x £4 x 52 = £416M
2M x £5 x 52 = £520M
2M x £6 x 52 = £624M
As per interview ramp up to 2.5m to 3m – this will give extra capacity to sell to private companies (airlines, schools, workplace & hospitals and overseas)
https://www.youtube.com/watch?v=7g8Kf_2wtrg
People are saying what is ODX gonna do when the pandemics is over. The testing is going to continue for many years because the governments cannot afford another pandemic and locking down the economy.
If the Covid testing business stops. The Profits could be reinvested to acquire new businesses.
Sign In
Follow the stocks
